Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients

Update Il y a 5 ans
Reference: EUCTR2008-006840-20

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate whether planned transition between 90 and 150 days post-transplantation to SRL-based therapy from TAC-based therapy is associated with a clinically relevant degree of improvement in renal function (≥ 5.0 mL/min/1.73 m2) compared to continuation of TAC-based therapy.


Inclusion criteria

  • Renal function in kidney transplant